SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001157523-18-001785
Filing Date
2018-08-09
Accepted
2018-08-09 16:03:23
Documents
2
Period of Report
2018-08-09

Document Format Files

Seq Description Document Type Size
1 AURINIA PHARMACEUTICALS INC. 6-K a51850845.htm 6-K 13087
2 EXHIBIT 99.1 a51850845ex99_1.htm EX-99.1 58483
  Complete submission text file 0001157523-18-001785.txt   72568
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 181004970
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1